Form 4 for NVAX NOVAVAX INC
Accepted 2024-06-20 00:00:00 ET · period of report 2024-06-17 · accession 0001593968-24-000879 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-06-20 | 2024-06-17 | NVAX | Dubovsky Filip | Pres, R, D | M - OptEx | $6.18 | +13.9K | 80.5K | +21% | +$85.9K |
| DM | 2024-06-20 | 2024-06-17 | NVAX | Dubovsky Filip | Pres, R, D | S - Sale+OE | $14.47 | -13.9K | 66.6K | -17% | -$201.2K |
| DM | 2024-06-20 | 2024-06-17 | NVAX | Dubovsky Filip | Pres, R, D | M - OptEx | $6.18 | -13.9K | 37.5K | -27% | -$85.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-17 | M | A | 1,404 | $6.97 | 68,017 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-17 | M | A | 12,500 | $6.09 | 80,517 | D | — | — | |
| 3 | Common | Common Stock | 2024-06-17 | S | D | 12,500 | $14.46 | 68,017 | D | — | — | |
| 4 | Common | Common Stock | 2024-06-17 | S | D | 1,404 | $14.54 | 66,613 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-06-17 | M | D | 1,404 | $6.97 | 46,324 | D | $6.97 · — to 2033-03-07 | 1,404 Common Stock | (F1) Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-06-17 | M | D | 12,500 | $6.09 | 37,500 | D | $6.09 · — to 2033-03-27 | 12,500 Common Stock | (F1) Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. |